MENU
+Compare
SNSE
Stock ticker: NASDAQ
AS OF
Jun 5 closing price
Price
$0.36
Change
+$0.01 (+2.86%)
Capitalization
9.1M

SNSE Sensei Biotherapeutics Forecast, Technical & Fundamental Analysis

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients... Show more

SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SNSE with price predictions
Jun 05, 2025

SNSE's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for SNSE turned positive on June 03, 2025. Looking at past instances where SNSE's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SNSE's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 03, 2025. You may want to consider a long position or call options on SNSE as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SNSE advanced for three days, in of 159 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

SNSE moved below its 50-day moving average on May 06, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNSE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SNSE entered a downward trend on June 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.284) is normal, around the industry mean (16.332). P/E Ratio (0.000) is within average values for comparable stocks, (59.787). SNSE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (263.647).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SNSE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNSE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SNSE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

SNSE is expected to report earnings to fall 40.74% to -15 cents per share on July 31

Sensei Biotherapeutics SNSE Stock Earnings Reports
Q2'25
Est.
$-0.16
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.01
The last earnings report on May 06 showed earnings per share of -27 cents, missing the estimate of -23 cents. With 134.04K shares outstanding, the current market capitalization sits at 9.10M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1405 Research Boulevard
Phone
+1 240 243-8000
Employees
27
Web
https://www.senseibio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USM62.531.22
+1.99%
United States Cellular Corp
WAFU1.420.02
+1.43%
Wah Fu Education Group Limited
CATX3.12-0.01
-0.32%
Perspective Therapeutics
NICE175.92-0.87
-0.49%
NICE Ltd
NAK1.19-0.01
-0.83%
Northern Dynasty Minerals Ltd

SNSE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNSE has been loosely correlated with VSTM. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SNSE jumps, then VSTM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNSE
1D Price
Change %
SNSE100%
+2.53%
VSTM - SNSE
47%
Loosely correlated
+0.16%
GRI - SNSE
40%
Loosely correlated
-4.14%
ALZN - SNSE
40%
Loosely correlated
-6.30%
INAB - SNSE
38%
Loosely correlated
-1.14%
FATE - SNSE
36%
Loosely correlated
-5.63%
More